Evogene's (EVGN) Biomica Signs Clinical Trial Agreement with Rambam Health Care Campus for Proof-of-Concept Trial of BMC128
Go back to Evogene's (EVGN) Biomica Signs Clinical Trial Agreement with Rambam Health Care Campus for Proof-of-Concept Trial of BMC128EVOGENE LTD. (NASDAQ: EVGN) | Delayed: 0.66 -0.01 (1.49%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.67 | 52 Week High | $9.32 | |||
Open | $0.65 | 52 Week Low | $5.79 | |||
Day High | $0.68 | P/E | N/A | |||
Day Low | $0.64 | EPS | $0.00 | |||
Volume | 28,248 |